All Episodes
|
110
|
Neil Meltzer

Podcast 110: ENCORE LifeBridge Health’s Focus on the Community with Neil Meltzer

Aug 7, 2020

Episode Summary

Today on Health Care Rounds, we are rebroadcasting a conversation with Neil Meltzer, President and CEO of LifeBridge Health. Meltzer shares details on how LifeBridge thrives in an intensely competitive Baltimore market and explains their visions for the future.This episode was originally uploaded on October 4th, 2018.

Episode Notes

Neil Meltzer, President and CEO of LifeBridge Health since 2013. Meltzer joined Sinai Hospital of Baltimore as Vice President of Operations in 1988, and a decade later became Sinai’s President and Chief Operating Officer.

Meltzer has a background in public health and brings a community-focused approach to every health care decision. He serves on the boards of the Greater Baltimore Committee, Notre Dame of Maryland University, the Maryland Hospital Association, the Hippodrome Foundation and Everyman Theatre. Additionally, Meltzer serves on the advisory board of the University of Maryland School of Public Health. On the national level, he continues to work with the American Heart Association after serving as national chairman. He was also one of 15 national workforce health care champions appointed by former president Barack Obama.

Meltzer earned his Master of Public Health and Health Administration from Tulane University School of Public Health and Tropical Medicine in Louisiana, and his undergraduate degree in public health from the University of Massachusetts Amherst.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and COO of Darwin Research Group, a health care market intelligence firm specializing in health care delivery systems. He’s a two-time health care entrepreneur, and his first company, FaxWatch, was listed twice on the Inc. 500 list of fastest-growing American companies. John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University and is an active member of the American College of Healthcare Executives.

About Darwin Research Group  

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
INsights
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.